To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS
Clinical trial NCT02869425 · WITHDRAWN
Trial details
- NCT number
- NCT02869425
- Sponsor
- RVL Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.